AD-PPA NPs
Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia
Treatment for Alzheimer's disease (AD), which currently focuses on inhibiting A β aggregation, fails to show effectiveness in people already presenting with symptoms of Alzheimer's disease. Strategies to synergexert neuroprotective effects and alleviate oxidative stress may be a promising approach to correct the pathological brain microenvironment. Based on the critical role of microglia in regulating the AD microenvironment, we describe here the development of Prussian blue / polyamide (PAMAM) dendrimer / Angiopep-2 (PPA) nanoparticles that regulate mitophagy in microglia as a potential AD therapy. PPA nanoparticles exhibit excellent blood-brain barrier (BBB) permeability and play a synergistic role in ROS clearance and restoring mitochondrial function in microglia. PPA nanoparticles effectively reduce neurotoxic A β aggregates and rescue cognitive function in the APP / PS1 model mice. Together, our data indicate that these multifunctional dendrimer nanoparticles exhibit effective neuroprotection and microglial modulation that can be promising as therapeutic approaches for AD.
18915694570
Previous： BK Engineering Bacteri
Next： Revascularization-β-HS
